30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Zynerba Pharmaceuticals Inc (ZYNE)

Track

Stock chart
Ticker: ZYNE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sebree Terri B
President
1 sale — total 16,440 USD
Sale 13 Sep 2023
Value US$4,649,022.58 | Price 478.21 | Shares 93,397
Sale 13 Sep 2023
Value US$1,316,423.00 | Price 202.87 | Shares 70,278
Sale 13 Sep 2023
Value US$23,637.23 | Price 1.33 | Shares 17,830
Sale 13 Sep 2023
Value US$11,928.65 | Price 1.33 | Shares 8,998
Sale 13 Sep 2023
Value US$8,499.06 | Price 1.33 | Shares 6,411
Sale 14 Jun 2023
Value US$40.03 | Price 0.35 | Shares 115
Sale 14 Jun 2023
Value US$40.03 | Price 0.35 | Shares 115
Sale 14 Jun 2023
Value US$40.03 | Price 0.35 | Shares 115
Sale 14 Jun 2023
Value US$40.03 | Price 0.35 | Shares 115
Sale 14 Jun 2023
Value US$40.03 | Price 0.35 | Shares 115
Sale 14 Jun 2023
Value US$40.03 | Price 0.35 | Shares 115
Sale 15 Feb 2023
Value US$1,719.13 | Price 0.54 | Shares 3,173
Sale 23 Jan 2023
Value US$7,569.94 | Price 0.60 | Shares 12,663
Sale 23 Jan 2023
Value US$10,622.31 | Price 0.60 | Shares 17,769
Sale 23 Jan 2023
Value US$21,193.80 | Price 0.60 | Shares 35,453
Sale 23 Jan 2023
Value US$14,742.35 | Price 0.60 | Shares 24,661
Sale 19 Jul 2022
Value US$6,614.30 | Price 1.10 | Shares 6,013
Sale 19 Jul 2022
Value US$9,109.10 | Price 1.10 | Shares 8,281
Sale 19 Jul 2022
Value US$4,717.90 | Price 1.10 | Shares 4,289
Sale 19 Jul 2022
Value US$13,088.90 | Price 1.10 | Shares 11,899
Sale 14 Jun 2022
Value US$40.40 | Price 1.01 | Shares 40
Sale 14 Jun 2022
Value US$40.40 | Price 1.01 | Shares 40
Sale 14 Jun 2022
Value US$40.40 | Price 1.01 | Shares 40
Sale 14 Jun 2022
Value US$53.53 | Price 1.01 | Shares 53
Sale 14 Jun 2022
Value US$40.40 | Price 1.01 | Shares 40
Sale 14 Jun 2022
Value US$40.40 | Price 1.01 | Shares 40
Buy 22 Aug 2018
Value US$32,153.00 | Price 6.43 | Shares 5,000
Buy 6 Aug 2018
Value US$22,047.60 | Price 5.80 | Shares 3,800
Buy 6 Aug 2018
Value US$89,422.50 | Price 5.96 | Shares 15,000
Buy 6 Aug 2018
Value US$22,013.40 | Price 5.79 | Shares 3,800
Buy 6 Aug 2018
Value US$50,842.24 | Price 5.97 | Shares 8,518
Buy 30 May 2018
Value US$61,498.25 | Price 10.45 | Shares 5,885
Buy 2 May 2018
Value US$156,945.00 | Price 10.46 | Shares 15,000
Buy 22 Mar 2018
Value US$92,790.00 | Price 9.28 | Shares 10,000
Buy 2 Jan 2018
Value US$194,847.00 | Price 12.99 | Shares 15,000
Buy 23 Oct 2017
Value US$255,794.60 | Price 9.94 | Shares 25,745
Buy 20 Oct 2017
Value US$293,538.00 | Price 9.78 | Shares 30,000
Buy 19 Oct 2017
Value US$424,405.45 | Price 9.59 | Shares 44,255
Buy 15 May 2017
Value US$29,355.00 | Price 19.57 | Shares 1,500
Buy 12 May 2017
Value US$103,064.00 | Price 19.82 | Shares 5,200
Buy 12 May 2017
Value US$69,160.00 | Price 19.76 | Shares 3,500
Buy 29 Dec 2016
Value US$158,500.00 | Price 15.85 | Shares 10,000
Buy 7 Dec 2016
Value US$56,120.00 | Price 14.03 | Shares 4,000
Buy 6 Dec 2016
Value US$42,450.00 | Price 14.15 | Shares 3,000
Sale 16 Aug 2016
Value US$31,590.00 | Price 10.53 | Shares 3,000
Buy 10 Aug 2015
Value US$175,000.00 | Price 14.00 | Shares 12,500
Buy 5 Aug 2015
Value US$53,760.00 | Price 17.92 | Shares 3,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-14 2023-09-13 S Sale
Sebree Terri B

President

Officer
93,397 -49.9%
478.21
US$4,649,023 		93,397 -49.9% 478.21 US$4,649,023
2023-09-14 2023-09-13 S Sale
Jones Kenneth T

See Remarks

Officer
70,278 -5.3%
202.87
US$1,316,423 		70,278 -5.3% 202.87 US$1,316,423
2023-09-14 2023-09-13 S Sale
3.2
ANIDO ARMANDO

Chairman & Chief Exec. Officer

Executive Director
89,410 -15.8%
172.72
US$820,268 		89,410 -15.8% 172.72 US$820,268
2023-09-14 2023-09-13 S Sale
Fickenscher James E

Chief Financial Officer

Officer
8,998 -2.3%
1.33
US$11,929 		8,998 -2.3% 1.33 US$11,929
2023-09-14 2023-09-13 S Sale
Rosenberger Brian

VP, Commercial & Business Dev.

Officer
6,411 -2.5%
1.33
US$8,499 		6,411 -2.5% 1.33 US$8,499
2023-06-15 2023-06-14 S Sale
FEDERICI WILLIAM J
Non-Executive Director
115 -0.2%
0.35
US$40 		115 -0.2% 0.35 US$40
2023-06-15 2023-06-14 S Sale
3.8
Butler John P.
Non-Executive Director
115 -0.1%
0.35
US$40 		115 -0.1% 0.35 US$40
2023-06-15 2023-06-14 S Sale
2.8
Stephenson Pamela
Non-Executive Director
115 -0.2%
0.35
US$40 		115 -0.2% 0.35 US$40
2023-06-15 2023-06-14 S Sale
COOPER WARREN D
Non-Executive Director
115 -0.2%
0.35
US$40 		115 -0.2% 0.35 US$40
2023-06-15 2023-06-14 S Sale
2.3
KISNER DANIEL L
Non-Executive Director
115 -0.2%
0.35
US$40 		115 -0.2% 0.35 US$40
2023-06-15 2023-06-14 S Sale
MOCH KENNETH I
Non-Executive Director
115 -0.2%
0.35
US$40 		115 -0.2% 0.35 US$40
2023-02-17 2023-02-15 S Sale
2.3
Parker Albert P

Chief Legal Officer

Officer
3,173 -1.4%
0.54
US$1,719 		3,173 -1.4% 0.54 US$1,719
2023-01-25 2023-01-23 S Sale
Rosenberger Brian

VP, Commercial & Business Dev.

Officer
12,663 -11.8%
0.60
US$7,570 		12,663 -11.8% 0.60 US$7,570
2023-01-25 2023-01-23 S Sale
Fickenscher James E

Chief Financial Officer

Officer
17,769 -10.3%
0.60
US$10,622 		17,769 -10.3% 0.60 US$10,622
2023-01-25 2023-01-23 S Sale
3.2
ANIDO ARMANDO

Chairman & Chief Exec. Officer

Executive Director
35,453 -5.8%
0.60
US$21,194 		35,453 -5.8% 0.60 US$21,194
2023-01-25 2023-01-23 S Sale
Sebree Terri B

President

Officer
24,661 -6.7%
0.60
US$14,742 		24,661 -6.7% 0.60 US$14,742
2022-07-20 2022-07-19 S Sale
Fickenscher James E

Chief Financial Officer

Officer
6,013 -3.4%
1.10
US$6,614 		6,013 -3.4% 1.10 US$6,614
2022-07-20 2022-07-19 S Sale
Sebree Terri B

President

Officer
8,281 -2.2%
1.10
US$9,109 		8,281 -2.2% 1.10 US$9,109
2022-07-20 2022-07-19 S Sale
Rosenberger Brian

VP, Commercial & Business Dev.

Officer
4,289 -3.8%
1.10
US$4,718 		4,289 -3.8% 1.10 US$4,718
2022-07-20 2022-07-19 S Sale
3.2
ANIDO ARMANDO

Chairman & CEO

Executive Director
11,899 -1.9%
1.10
US$13,089 		11,899 -1.9% 1.10 US$13,089
2022-06-16 2022-06-14 S Sale
FEDERICI WILLIAM J
Non-Executive Director
40 -0.1%
1.01
US$40 		40 -0.1% 1.01 US$40
2022-06-16 2022-06-14 S Sale
MOCH KENNETH I
Non-Executive Director
40 -0.1%
1.01
US$40 		40 -0.1% 1.01 US$40
2022-06-16 2022-06-14 S Sale
2.8
Stephenson Pamela
Non-Executive Director
40 -0.1%
1.01
US$40 		40 -0.1% 1.01 US$40
2022-06-16 2022-06-14 S Sale
3.8
Butler John P.
Non-Executive Director
53 -0.2%
1.01
US$54 		53 -0.2% 1.01 US$54
2022-06-16 2022-06-14 S Sale
COOPER WARREN D
Non-Executive Director
40 -0.1%
1.01
US$40 		40 -0.1% 1.01 US$40
2022-06-16 2022-06-14 S Sale
2.3
KISNER DANIEL L
Non-Executive Director
40 -0.1%
1.01
US$40 		40 -0.1% 1.01 US$40
2018-08-22 2018-08-22 B Purchase Butler John P. Non-Executive Director
5,000 +inf%
6.43
US$32,153 		5,000 +inf% 6.43 US$32,153
2018-08-07 2018-08-06 B Purchase Hanlon Suzanne M.

Sec, VP & General Counsel

Officer
3,800 +9.5%
5.80
US$22,048 		3,800 +9.5% 5.80 US$22,048
2018-08-07 2018-08-06 B Purchase ANIDO ARMANDO

Chairman & Chief Exec. Officer

Executive Director
15,000 +4.4%
5.96
US$89,422 		15,000 +4.4% 5.96 US$89,422
2018-08-07 2018-08-06 B Purchase Sebree Terri B

President

Officer
3,800 +2.1%
5.79
US$22,013 		3,800 +2.1% 5.79 US$22,013
2018-08-07 2018-08-06 B Purchase Fickenscher James E

Chief Financial Officer

Officer
8,518 +69.8%
5.97
US$50,842 		8,518 +69.8% 5.97 US$50,842
2018-05-31 2018-05-30 B Purchase RAPP MICHAEL Large shareholder
5,885 +0.4%
10.45
US$61,498 		5,885 +0.4% 10.45 US$61,498
2018-05-02 2018-05-02 B Purchase RAPP MICHAEL Large shareholder
15,000 +1.0%
10.46
US$156,945 		15,000 +1.0% 10.46 US$156,945
2018-03-23 2018-03-22 B Purchase RAPP MICHAEL Large shareholder
10,000 +0.7%
9.28
US$92,790 		10,000 +0.7% 9.28 US$92,790
2018-01-03 2018-01-02 B Purchase RAPP MICHAEL Large shareholder
15,000 +1.0%
12.99
US$194,847 		15,000 +1.0% 12.99 US$194,847
2017-10-23 2017-10-23 B Purchase RAPP MICHAEL Large shareholder
25,745 +1.8%
9.94
US$255,795 		25,745 +1.8% 9.94 US$255,795
2017-10-23 2017-10-20 B Purchase RAPP MICHAEL Large shareholder
30,000 +2.1%
9.78
US$293,538 		30,000 +2.1% 9.78 US$293,538
2017-10-23 2017-10-19 B Purchase RAPP MICHAEL Large shareholder
44,255 +3.3%
9.59
US$424,405 		44,255 +3.3% 9.59 US$424,405
2017-05-16 2017-05-15 B Purchase ANIDO ARMANDO

Chairman & Chief Exec. Officer

Executive Director
1,500 +0.4%
19.57
US$29,355 		1,500 +0.4% 19.57 US$29,355
2017-05-16 2017-05-12 B Purchase Fickenscher James E

Chief Financial Officer

Officer
5,200 +74.3%
19.82
US$103,064 		5,200 +74.3% 19.82 US$103,064
2017-05-16 2017-05-12 B Purchase ANIDO ARMANDO

Chairman & Chief Exec. Officer

Executive Director
3,500 +1.1%
19.76
US$69,160 		3,500 +1.1% 19.76 US$69,160
2016-12-29 2016-12-29 B Purchase RAPP MICHAEL Large shareholder
10,000 +0.7%
15.85
US$158,500 		10,000 +0.7% 15.85 US$158,500
2016-12-08 2016-12-07 B Purchase Fickenscher James E

Chief Financial Officer

Officer
4,000 +133.3%
14.03
US$56,120 		4,000 +133.3% 14.03 US$56,120
2016-12-08 2016-12-06 B Purchase Fickenscher James E

Chief Financial Officer

Officer
3,000 +inf%
14.15
US$42,450 		3,000 +inf% 14.15 US$42,450
2016-08-17 2016-08-16 S Sale Hanlon Suzanne M.

Sec, General Counsel & VP HR

Officer
3,000 -100.0%
10.53
US$31,590 		3,000 -100.0% 10.53 US$31,590
2015-08-12 2015-08-10 B Purchase HARRISON THOMAS L Non-Executive Director
12,500 +inf%
14.00
US$175,000 		12,500 +inf% 14.00 US$175,000
2016-08-17 2015-08-05 B Purchase Hanlon Suzanne M.

Sec, General Counsel & VP HR

Officer
3,000 +inf%
17.92
US$53,760 		3,000 +inf% 17.92 US$53,760
Explore more

More insider trading research around Zynerba Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America